Oncolytic virotherapy armed with an engineered interfering lncRNA exhibits antitumor activity by blocking the epithelial mesenchymal transition in triple-negative breast cancer. - Ang, Lin; Guo, Lingli; Wang, Jin; Huang, Jin; Lou, Xiaoli; Zhao, Min (Cancer Letters, 2020)